Australian manufacturer thrives at intersection of technology and human wellbeing
From Manufacturers' Monthly:
Ringwood’s Trajan Scientific and Medical operates in two acknowledged areas of competitive advantage for Australia: advanced manufacturing and medical technology. Brent Balinski spoke to company CEO Stephen Tomisich about how it plans to change the world of healthcare.
Read the full article at Manufacturers' Monthly: Australian manufacturer thrives at intersection of technology and human wellbeing
Stephen Tomisich, Director and Chief Executive Officer, Trajan Scientific and Medical
Also in News
Interview: Why data quality plays a critical role in personalized medicine, with microsampling expert Dr Michele Protti
Trajan Scientific and Medical’s hemaPEN® microsampling technology has been developed with extensive consultation and evaluation by leading analytical laboratories, clinicians and healthcare professionals.
This month, Trajan presents an exclusive interview with researcher Dr Michele Protti of Pharmaco-Toxicological Analysis, Bologna, Italy, on the future of microsampling and the critical role hemaPEN can play when used in therapeutic drug monitoring for optimal therapy personalization.
Trajan celebrates International Pathology Day with ScyTek Laboratories to deliver quality IHC solutions
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.